Become a CELS Member and see additional member information and private messaging!

Most CELS events including the VR Webinars include a coupon code for free individual and Start-Up (Bundled Individual) memberships, that can be used here. Join CELS now start exploring your instant Life Science network!

You have an idea of how your technology can improve healthcare, however, the road to market has curves you need to successfully maneuver. There are important regulatory and market considerations you need to understand and prepare for early in the development cycle.

In this forum, you will hear from a successful Canadian startup using a smartphone app to improve wound care followed by a panel of regulatory and investment professionals that will help you understand:

Regulatory hurdles and opportunities in the Health Tech space

The importance of current workflows and standards of care

Investor insights - what interests them, why and where they are looking to invest

Raising Health Tech funds in the Valley

Upcoming changes in the FDA approach to regulating digital health and implications for device companies.

NOTE: Virtual Guests - The event will be available in a webinar format with Q&A questions submitted by chat mode

Speakers

Ali Farahanchi | Vice President | DHVC (Danhua Capital)

Ali is investor with DHVC, an early-stage tech and life science fund in Palo Alto. With more than $650M assets under management and 100+ companies in its portfolio, DHVC invests in variety of areas in healthcare including therapeutics, diagnostics and tools, and digital health, with strong emphasis on novel mechanisms and data-driven platforms. Previously Ali has worked in research and in consulting roles in semiconductor and healthcare industries, and has obtained graduate degrees in engineering and management from MIT and University of Chicago.

Carlo Perez | Founder & CEO | Swift Medical

Carlo Perez is an engineer and entrepreneur, passionate about delivering designs and transformative technologies that put empathy into action. Raised by a father who was a trained engineer and a mother who worked as a nurse, Carlo spent seven years in R&D at Advanced Micro Devices (AMD) Inc., where his research focused on industry-leading 3D graphics hardware. In 2009, after a year of hitchhiking, Carlo found a calling teaching post-graduate engineering at Humber College, covering subjects that ranged from RF technology to advanced robotics. During this time, he explored novel applications of state-of-the-art visioning technology with his future Swift Medical co-founders – a path that led them to wound care. Today, after three short years, Swift Medical is the category leader in digital wound care management, adopted by over 1,000 facilities to monitor over 100,000 beds across North America.

Internationally recognized expert in risk management and serve on international standards and policy making bodies. Addressed numerous industry forums and the press on issues of emerging health technologies and innovation trends, especially for connected medical technologies.

Computational Care is DCVC’s deep data thesis applied to the patient journey and all aspects of the provision of care, almost always with a combination of deep compute, evidence, and empathy.

Scott is based in Palo Alto and invests globally.

As examples, Scott has invested in or sits on the board of:

Swift Medical- machine vision to wound care at bedside

Karius- hypothesis-free infectious disease testing

MIC- deep compute in ICU

Subtle Medical- deep learning applied to imaging efficiency

Alpha Medical- full-stack digital clinic

Enzyme- FDA submission and compliance as a service

SafelyYou- machine vision in elder care

Noteworth- platform for prescribing sensors and biomarkers

Scott is also part of DCVCs Computational Bio practice (Freenome, Recursion, 3Scan, Cofactor) and invests in the tech stack and against global risk (ElementAI, Cape Analytics, BlueTalon).

By background, Scott has been a founder, a serial angel investor (naviHealth, Syapse, Carelinx, Lumiata, etc), and a large company executive. Scott helped create and scale the first massive digital health platform- Surescripts- and served CVS Health as a GM and innovation leader across the company's healthcare and retail assets.

Earlier Scott worked for the Boston Consulting Group (BCG) and started a capital markets desk in London for Banc of America Securities. Scott received an MBA from INSEAD in Fontainebleau France and was militantly liberal arts and math and science at the University of Virginia.a football quarterback and manufacturing floor worker in his small Virginia town.